Form 4: Enhabit, Inc. Executive Ronald Leroy Langham JR Reports Changes in Beneficial Ownership
SEC Form 4 Filing
EVP Clinical Excellence & Strategy, Ronald Leroy Langham JR, reports acquisition and disposal of Enhabit, Inc. common stock on March 6, 2025.
Summary
- On March 6, 2025, Ronald Leroy Langham JR, EVP Clinical Excellence & Strategy at Enhabit, Inc., reported changes in beneficial ownership of the company's common stock.
- Langham acquired 7,092 shares of common stock at a price of $8.02 per share.
- He also disposed of 2,377 shares of common stock at $8.02 per share.
- Following these transactions, Langham directly owns 56,164 shares of Enhabit, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key personnel and their confidence in the company.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how the market interprets the insider's actions.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of stock acquisition and disposal transactions. |
| 03/10/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.